A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
about
Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast CancerYAP promotes tumorigenesis and cisplatin resistance in neuroblastomaThe Architectural Chromatin Factor High Mobility Group A1 Enhances DNA Ligase IV Activity Influencing DNA RepairCullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway.Gene expression profiling of the 8q22-24 position in human breast cancer: TSPYL5, MTDH, ATAD2 and CCNE2 genes are implicated in oncogenesis, while WISP1 and EXT1 genes may predict a risk of metastasis.YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins.PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer.Knockdown of Long Non-Coding RNA KCNQ1OT1 Restrained Glioma Cells' Malignancy by Activating miR-370/CCNE2 Axis.High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy.HMGA1 regulates the Plasminogen activation system in the secretome of breast cancer cells.The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas.Role of high mobility group A1 and body mass index in the prognosis of patients with breast cancer.Regulation of Tissue Growth by the Mammalian Hippo Signaling Pathway.miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1.Transcriptional Regulation of Glucose Metabolism: The Emerging Role of the HMGA1 Chromatin Factor
P2860
Q31015478-BF42580B-4F1D-4113-BCAA-E2936508D425Q33913845-004BC041-0297-4EA4-9347-4C1E2EA1D473Q36159491-4DE9EF40-7AF6-40FC-8C92-D8A179859115Q36962867-8336CA0F-1F84-4D02-A119-C3FDB9B33B67Q37407194-E14F91E2-0B9E-49C0-A418-81586F282902Q37623308-0616E774-2B68-45A9-9968-9C860C661D50Q37630473-7FC884E1-E269-4892-A6A5-6B9D803224B3Q37714468-4F752099-1EF4-4FC9-B5D6-01BF87E806A2Q38807021-D5409D78-5159-46F8-B8A4-9A77E42124D3Q41717944-3EC296DA-6695-470B-98A0-81F9E9760CE6Q42516196-18961201-FAE8-44F2-8EE6-5A921B6C977DQ43809683-ECD65626-2894-4956-9940-8AB676B0FE53Q47100063-394C7102-0FA6-4ABA-8211-2569A4B2F3FDQ55315505-40FCA198-9D1F-4BDA-B1AB-1696F4BFDD6BQ57177289-81319C4A-A18A-48C7-B91E-E26D902D57E6
P2860
A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
@ast
A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
@en
type
label
A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
@ast
A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
@en
prefLabel
A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
@ast
A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
@en
P2860
P50
P356
P1433
P1476
A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
@en
P2093
Guidalberto Manfioletti
Riccardo Sgarra
P2860
P304
19087-19101
P356
10.18632/ONCOTARGET.4236
P407
P577
2015-05-22T00:00:00Z